Skip to main content
. Author manuscript; available in PMC: 2014 Jul 8.
Published in final edited form as: Clin Cancer Res. 2013 Aug 21;19(19):5505–5512. doi: 10.1158/1078-0432.CCR-12-3327

Table 3.

Bicalutamide-related adverse events per NCI CTCAE version 3

Toxicity Grade 1
(n)
Grade 2
(n)
Grade 3
(n)
AST 5 1 1
ALT 5 1
Hyperbilirubinemia 1
Alkaline phosphatase 1 1
Nausea 1
Pain
  Headache, back, other 3
  Breast 3
  Limb 3
Constipation 1
Anorexia 3 1
Fatigue 5 1
Hemoglobin 1
Vaginal dryness 1
Diarrhea 3
Hot flashes 6
Limb edema 6

NOTE: Grade 1 toxicities reported in >10% of patients (n = 28). No grade 4 or 5 events or treatment-related serious adverse events observed.